Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver Cirrhosis

BACKGROUNDTreatment of portal vein thrombosis (PVT) in patients with liver cirrhosis is not well established. AIMWe intended to assess the safety and efficacy of low molecular weight heparin (LMWH) to treat PVT in cirrhotic patients. STUDYAll 39 patients diagnosed with non-neoplastic PVT and cirrhos...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical gastroenterology 2010-07, Vol.44 (6), p.448-451
Hauptverfasser:	Amitrano, Lucio, Guardascione, Maria Anna, Menchise, Antonella, Martino, Rossana, Scaglione, Mariano, Giovine, Sabrina, Romano, Luigia, Balzano, Antonio
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - therapeutic use Biological and medical sciences Blood and lymphatic vessels Blood. Blood coagulation. Reticuloendothelial system Cardiology. Vascular system Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Female Gastroenterology. Liver. Pancreas. Abdomen Heparin, Low-Molecular-Weight - administration & dosage Heparin, Low-Molecular-Weight - adverse effects Heparin, Low-Molecular-Weight - therapeutic use Humans Liver Cirrhosis - complications Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged Other diseases. Semiology Pharmacology. Drug treatments Portal Vein Treatment Outcome Venous Thrombosis - drug therapy Venous Thrombosis - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!